| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BMCL.2013.04.055 |
| P8608 | Fatcat ID | release_b5z7plclbrdwtiygssoicaxubu |
| P932 | PMC publication ID | 3691018 |
| P698 | PubMed publication ID | 23664213 |
| P2093 | author name string | Bing Li | |
| Daniel Aiello | |||
| Donald T Moir | |||
| Norton P Peet | |||
| Terry L Bowlin | |||
| Ramdas Pai | |||
| Marjorie H Barnes | |||
| Ming Di | |||
| P2860 | cites work | Inhibition of DNA helicase, ATPase and DNA-binding activities of E. coli RecQ helicase by chemotherapeutic agents. | Q54426102 |
| Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department | Q55897489 | ||
| Time-Resolved Fluorescence Energy Transfer DNA Helicase Assays for High Throughput Screening | Q73851674 | ||
| Development of a novel helicase assay using electrochemiluminescence | Q73927470 | ||
| FlashPlate scintillation proximity assays for characterization and screening of DNA polymerase, primase, and helicase activities | Q77068313 | ||
| Myricetin inhibits Escherichia coli DnaB helicase but not primase | Q81240209 | ||
| Inhibition of DNA helicases with DNA-competitive inhibitors | Q81510750 | ||
| Isolation of the Cdc45/Mcm2-7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase | Q24548452 | ||
| Structure of hexameric DnaB helicase and its complex with a domain of DnaG primase | Q27648844 | ||
| The hexameric helicase DnaB adopts a nonplanar conformation during translocation. | Q27673737 | ||
| Homogenous assays for Escherichia coli DnaB-stimulated DnaG primase and DnaB helicase and their use in screening for chemical inhibitors | Q31055527 | ||
| Triaminotriazine DNA helicase inhibitors with antibacterial activity | Q33229184 | ||
| Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicases | Q33455209 | ||
| Inhibitors of DNA polymerase III as novel antimicrobial agents against gram-positive eubacteria | Q33977434 | ||
| Structure and function of hexameric helicases. | Q34019405 | ||
| Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. | Q34214929 | ||
| Coumarin-based inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicase: chemical optimization, biological evaluation, and antibacterial activities | Q36492284 | ||
| High-throughput determination of mode of inhibition in lead identification and optimization | Q38449116 | ||
| Low frequencies of resistance among Staphylococcus and Enterococcus species to the bactericidal DNA polymerase inhibitor N(3)-hydroxybutyl 6-(3'-ethyl-4'-methylanilino) uracil | Q39671152 | ||
| Development of novel inhibitor probes of DNA polymerase III based on dGTP analogs of the HPUra type: base, nucleoside and nucleotide derivatives of N2-(3,4-dichlorobenzyl)guanine | Q40527605 | ||
| New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay | Q41358370 | ||
| Inhibition of bacterial DNA replication by 6-(p-hydroxy-phenylazo)-uracil. | Q42232459 | ||
| Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). | Q43830712 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3481-3486 | |
| P577 | publication date | 2013-04-30 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
| P1476 | title | Optimization of a novel potent and selective bacterial DNA helicase inhibitor scaffold from a high throughput screening hit. | |
| P478 | volume | 23 |
| Q28075453 | Alternative pre-approved and novel therapies for the treatment of anthrax |
| Q35877840 | Benzobisthiazoles Represent a Novel Scaffold for Kinase Inhibitors of CLK Family Members |
| Q92478635 | Blocking the Trigger: Inhibition of the Initiation of Bacterial Chromosome Replication as an Antimicrobial Strategy |
| Q46478240 | Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis |
| Q52322877 | The Human Replicative Helicase, the CMG Complex, as a Target for Anti-cancer Therapy. |
Search more.